|
[1]
|
Holmes, R.S. and Vaughan, T.L. (2007) Epidemiology and Pathogenesis of Esophageal Cancer. Seminars in Radiation Oncology, 17, 2-9. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Pennathur, A., Gibson, M.K., Jobe, B.A. and Luketich, J.D. (2013) Oesophageal Carcinoma. The Lancet, 381, 400-412. [Google Scholar] [CrossRef]
|
|
[3]
|
Ohashi, S., Miyamoto, S., Kikuchi, O., Goto, T., Amanuma, Y. and Muto, M. (2015) Recent Advances from Basic and Clinical Studies of Esophageal Squamous Cell Carcinoma. Gastroenterology, 149, 1700-1715. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Okugawa, Y., Grady, W.M. and Goel, A. (2015) Epigenetic Alterations in Colorectal Cancer: Emerging Biomarkers. Gastroenterology, 149, 1204-1225.e12. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Shen, H. and Laird, P.W. (2013) Interplay between the Cancer Genome and Epigenome. Cell, 153, 38-55. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Esteller, M. (2011) Epigenetic Changes in Cancer. F1000 Biology Reports, 3, 9. [Google Scholar] [CrossRef]
|
|
[7]
|
Rastgoo, N., Abdi, J., Hou, J. and Chang, H. (2017) Role of Epi-genetics-MicroRNA Axis in Drugresistance of Multiple Myeloma. Journal of Hematology & Oncology, 10, Article No. 121. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Wang, L., Meng, D., Wang, Y. and Hu, J. (2018) Long Non-Coding RNA LINC01296 Promotes Esophageal Squamous Cell Carcinoma Cell Proliferation and Invasion by Epigenetic Suppression of KLF2. American Journal of Cancer Research, 8, 2020-2029.
|
|
[9]
|
Lin, D.C., Wang, M.R. and Koeffler, H.P. (2018) Genomic and Epigenomic Aberrations in Esophageal Squamous Cell Carcinoma and Impli-cations for Patients. Gastroenterology, 154, 374-389. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Bird, A. (2002) DNA Methylation Patterns and Epigenetic Memory. Genes & Development, 16, 6-21. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Lv, J.F., Hu, L., Zhuo, W., Zhang, C.M., Zhou, H.H. and Fan, L. (2016) Epigenetic Alternations and Cancer Chemotherapy Response. Cancer Chemotherapy and Pharmacology, 77, 673-684. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Sharma, S., Kelly, T.K. and Jones, P.A. (2010) Epigenetics in Cancer. Carcinogenesis, 31, 27-36. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Gonzalez-Ramirez, I., Soto-Reyes, E., Sanchez-Perez, Y., Herrera, L.A. and Garcia-Cuellar, C. (2014) Histones and Long Non-Coding RNAs: The New Insights of Epigenetic De-Regulation Involved in Oral Cancer. Oral Oncology, 50, 691-695. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
张健, 邵生辉, 彭雅琼, 等. 沉默长链非编码RNA ANO1-AS1对食管鳞癌细胞迁移、侵袭的影响[J]. 中国老年学杂志, 2024, 44(1): 75-81.
|
|
[15]
|
黄建伟, 李玉凤, 张权, 等. 长链非编码RNA SNHG1靶向miR-340-5p/CCND1轴调控食管癌细胞增殖、迁移和侵袭[J]. 现代肿瘤医学, 2023, 31(12): 2209-2215.
|
|
[16]
|
Meissner, A., Mikkelsen, T.S., Gu, H., Wernig, M., Hanna, J., Sivachenko, A., et al. (7205) Genome-Scale DNA Methylation Maps of Pluripotent and Differentiated Cells. Nature, 454, 766-770. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Alipour, S., Nouri, M., Sakhinia, E., Samadi, N., Roshanravan, N., Ghavami, A. and Khabbazi, A. (2017) Epigenetic Alterations in Chronic Disease Focusing on Behcet’s Disease: Review. Biomedicine & Pharmacotherapy, 91, 526-533. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Herman, J.G. and Baylin, S.B. (2003) Gene Silencing in Cancer in Association with Promoter Hypermethylation. The New England Journal of Medicine, 349, 2042-2054. [Google Scholar] [CrossRef]
|
|
[19]
|
Weber, M., Hellmann, I., Stadler, M.B., Ramos, L., Paabo, S., Rebhan, M. and Schubeler, D. (2007) Distribution, Silencing Potential and Evolutionary Impact of Promoter DNA Methylation in the Human Genome. Nature Genetics, 39, 457-466. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Ziller, M.J., Gu, H., Muller, F., Donaghey, J., Tsai, L.T., Kohlbacher, O., et al. (2013) Charting a Dynamic DNA Methylation Landscape of the Human Genome. Nature, 500, 477-481. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Sigalotti, L., Covre, A., Fratta, E., Parisi, G., Colizzi, F., Rizzo, A., et al. (2010) Epigenetics of Human Cutaneous Melanoma: Setting the Stage for New Therapeutic Strategies. Journal of Translational Medicine, 8, Article No. 56. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Klose, R.J. and Bird, A.P. (2006) Genomic DNA Methylation: The Mark and Its Mediators. Trends in Biochemical Sciences, 31, 89-97. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Chen, X., Ge, X., Wang, J., Tan, C., King, G.J. and Liu, K. (2015) Genome-Wide DNA Methylation Profiling by Modified Reduced Representation Bisulfite Sequencing in Brassica rapa Suggests That Epigenetic Modifications Play a Key Role in Polyploid Genome Evolution. Frontiers in Plant Science, 6, Article 836. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
陈曦, 王雅梅. 胶质瘤化疗耐药机制的表观遗传学调控研究进展[J]. 癌症进展, 2023, 21(20): 2205-2211+2259.
|
|
[25]
|
Jenuwein, T. and Allis, C.D. (2001) Translating the Histone Code. Science, 293, 1074-1080. [Google Scholar] [CrossRef] [PubMed]
|
|
[26]
|
Xu, F., Zhang, K. and Grunstein, M. (2005) Acetylation in Histone H3 Globular Domain Regulates Gene Expression in Yeast. Cell, 121, 375-385. [Google Scholar] [CrossRef] [PubMed]
|
|
[27]
|
Greer, E.L. and Shi, Y. (2012) Histone Methylation: A Dynamic Mark in Health, Disease and Inheritance. Nature Reviews Genetics, 13, 343-357. [Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
Zhang, Y. and Reinberg, D. (2001) Transcription Regulation by Histone Methylation: Interplay between Different Covalent Modifications of the Core Histone Tails. Genes & Development, 15, 2343-2360. [Google Scholar] [CrossRef] [PubMed]
|
|
[29]
|
Dawson, M.A. and Kouzarides, T. (2012) Cancer Epigenetics: From Mechanism to Therapy. Cell, 150, 12-27. [Google Scholar] [CrossRef] [PubMed]
|
|
[30]
|
Baylin, S.B. and Jones, P.A. (2011) A Decade of Exploring the Cancer Epigenome—Biological and Translational Implications. Nature Reviews Cancer, 11, 726-734. [Google Scholar] [CrossRef] [PubMed]
|
|
[31]
|
Alam, H., Gu, B. and Lee, M.G. (2015) Histone Methylation Modifiers in Cellular Signaling Pathways. Cellular and Molecular Life Sciences, 72, 4577-4592. [Google Scholar] [CrossRef] [PubMed]
|
|
[32]
|
Lund, A.H. and Van Lohuizen, M. (2004) Polycomb Complexes and Silencing Mechanisms. Current Opinion in Cell Biology, 16, 239-246. [Google Scholar] [CrossRef] [PubMed]
|
|
[33]
|
Jin, Y., Huo, B., Fu, X., Hao, T., Zhang, Y., Guo, Y. and Hu, X. (2017) LSD1 Collaborates with EZH2 to Regulate Expression of Interferon-Stimulated Genes. Biomedicine & Phar-macotherapy, 88, 728-737. [Google Scholar] [CrossRef] [PubMed]
|
|
[34]
|
Chen, C., Zhao, M., Yin, N., He, B., Wang, B., Yuan, Y., et al. (2011) Abnormal Histone Acetylation and Methylation Levels in Esophageal Squamous Cell Carcinomas. Cancer In-vestigation, 29, 548-556. [Google Scholar] [CrossRef] [PubMed]
|
|
[35]
|
Kouzarides, T. (2007) Chromatin Modifications and Their Function. Cell, 128, 693-705. [Google Scholar] [CrossRef] [PubMed]
|
|
[36]
|
Bannister, A.J., Zegerman, P., Partridge, J.F., Miska, E.A., Thomas, J.O., Allshire, R.C. and Kouzarides, T. (2001) Selective Recognition of Methylated Lysine 9 on Histone H3 by TheHP1 Chromo Domain. Nature, 410, 120-124. [Google Scholar] [CrossRef] [PubMed]
|
|
[37]
|
Schizas, D., Mastoraki, A., Naar, L., Spartalis, E., Tsilimigras, D.I., Karachaliou, G.S., et al. (2018) Concept of Histone Deacetylases in Cancer: Reflections on Esophageal Carcinogenesis and Treatment. World Journal of Gastroenterology, 24, 4635-4642. [Google Scholar] [CrossRef] [PubMed]
|
|
[38]
|
魏毅君. 长链非编码RNA Linc00578促进胰腺癌细胞增殖和侵袭的作用和机制[D]: [硕士学位论文]. 苏州: 苏州大学, 2021.[CrossRef]
|
|
[39]
|
Pauli, A., Rinn, J.L. and Schier, A.F. (2011) Non-Coding RNAs as Regulators of Embryogenesis. Nature Reviews Genetics, 12, 136-149. [Google Scholar] [CrossRef] [PubMed]
|
|
[40]
|
Costa, F.F. (2005) Non-Coding RNAs: New Players in Eukaryotic Biology. Gene, 357, 83-94. [Google Scholar] [CrossRef] [PubMed]
|
|
[41]
|
Ponjavic, J., Ponting, C.P. and Lunter, G. (2007) Functionality or Transcriptional Noise Evidence for Selection within Long Noncoding RNAs. Genome Research, 17, 556-565. [Google Scholar] [CrossRef] [PubMed]
|
|
[42]
|
Anastasiadou, E., Jacob, L.S. and Slack, F.J. (2018) Non-Coding RNA Networks in Cancer. Nature Reviews Cancer, 18, 5-18. [Google Scholar] [CrossRef] [PubMed]
|
|
[43]
|
Rathinasamy, B. and Velmurugan, B.K. (2018) Role of lncRNAs in the Cancer Development and Progression and Their Regulation by Various Phytochemicals. Biomedicine & Pharmacotherapy, 102, 242-248. [Google Scholar] [CrossRef] [PubMed]
|
|
[44]
|
Zhang, Y., Yang, P. and Wang, X.F. (2014) Microenvironmental Regulation of Cancer Metastasis by miRNAs. Trends in Cell Biology, 24, 153-160. [Google Scholar] [CrossRef] [PubMed]
|
|
[45]
|
Lee, R.C., Feinbaum, R.L. and Ambros, V. (1993) The C. Elegans Heterochronic Gene Lin-4 En-Codes Small RNAs with Antisense Complementarity to Lin-14. Cell, 75, 843-854. [Google Scholar] [CrossRef]
|
|
[46]
|
Ambros, V. (2004) The Functions of Animal MicroRNAs. Nature, 431, 350-355. [Google Scholar] [CrossRef] [PubMed]
|
|
[47]
|
Bartel, D.P. (2004) MicroRNAs: Genomics, Bi-ogenesis, Mechanism, and Function. Cell, 116, 281-297. [Google Scholar] [CrossRef]
|
|
[48]
|
Liu, H., Zhang, Q., Lou, Q., Zhang, X., Cui, Y., Wang, P., et al. (2020) Differential Analysis of lncRNA, miRNA and MRNA Expression Profiles and the Prognostic Value of lncRNA in Esophageal Cancer. Pathology and Oncology Research, 26, 1029-1039. [Google Scholar] [CrossRef] [PubMed]
|
|
[49]
|
Kong, K.L., Kwong, D.L., Chan, T.H., Law, S.Y., Chen, L., Li, Y., et al. (2012) MicroRNA-375 Inhibits Tumour Growth and Metastasis in Oesophageal Squamous Cell Carcinoma through Repressing Insulin-Like Growth Factor 1 Receptor. Gut, 61, 33-42. [Google Scholar] [CrossRef] [PubMed]
|
|
[50]
|
Zhang, N., Fu, H., Song, L., Ding, Y., Wang, X., Zhao, C., et al. (2014) MicroRNA-100 Promotes Migration and Invasion through Mammalian Target of Rapamycin in Esophageal Squamous Cell Carcinoma. Oncology Reports, 32, 1409-1418. [Google Scholar] [CrossRef] [PubMed]
|
|
[51]
|
Wang, Y., Hu, Y., Guo, J. and Wang, L. (2019) miR-148a-3p Sup-presses the Proliferation and Invasion of Esophageal Cancer by Targeting DNMT1. Genetic Testing and Molecular Biomarkers, 23, 98-104. [Google Scholar] [CrossRef] [PubMed]
|
|
[52]
|
Zhang, K., Wu, X., Wang, J., Lopez, J., Zhou, W., Yang, L., et al. (2016) Circulating miRNA Profile in Esophageal Adenocarcinoma. American Journal of Cancer Research, 6, 2713-2721.
|
|
[53]
|
Gu, J., Zhang, J., Zheng, L., Ajani, J.A., Wu, X. and Ye, Y. (2018) Serum miR-331-3p Predicts Tu-mor Recurrence in Esophageal Adenocarcinoma. Scientific Reports, 8, Article No. 14006. [Google Scholar] [CrossRef] [PubMed]
|
|
[54]
|
Stein, L.D. (7011) Human Genome: End of the Beginning. Na-ture, 431, 915-916. [Google Scholar] [CrossRef] [PubMed]
|
|
[55]
|
Derrien, T., Johnson, R., Bussotti, G., Tanzer, A., Djebali, S., Tilgner, H., et al. (2012) The GENCODE V7 Catalog of Human Long Noncoding RNAs: Analysis of Their Gene Structure, Evolution, and Expression. Genome Research, 22, 1775-1789. [Google Scholar] [CrossRef] [PubMed]
|
|
[56]
|
Su, M., Xiao, Y., Ma, J., Cao, D., Zhou, Y., Wang, H., et al. (2018) Long Non-Coding RNAs in Esophageal Cancer: Molecular Mechanisms, Functions, and Potential Applications. Journal of Hematology & Oncology, 11, Article No. 118. [Google Scholar] [CrossRef] [PubMed]
|
|
[57]
|
Huang, X., Zhou, X., Hu, Q., Sun, B., Deng, M., Qi, X. and Lu, M. (2018) Advances in Esophageal Cancer: A New Perspective on Pathogenesis Associated with Long Non-Coding RNAs. Cancer Letters, 413, 94-101. [Google Scholar] [CrossRef] [PubMed]
|
|
[58]
|
Han, G.H., Lu, K.J., Wang, P., Ye, J., Ye, Y.Y. and Huang, J.X. (2018) lncRNA SNHG16 Predicts Poor Prognosis in ESCC and Promotes Cell Proliferation and Invasion by Regulating Wnt/Beta-Catenin Signaling Pathway. European Review for Medical and Pharmacological Sciences, 22, 3795-3803.
|
|
[59]
|
Zhou, X.L., Wang, W.W., Zhu, W.G., Yu, C.H., Tao, G.Z., Wu, Q.Q., et al. (2016) High Expression of Long Non-Coding RNA AFAP1-AS1 Predicts Chemoradioresistance and Poor Prognosis in Patients with Esophageal Squamous Cell Carcinoma Treated with Definitive Chemoradiotherapy. Molecular Carcinogenesis, 55, 2095-2105. [Google Scholar] [CrossRef] [PubMed]
|
|
[60]
|
Wang, W., Zhu, Y., Li, S., Chen, X., Jiang, G., Shen, Z.Y., et al. (2016) Long Noncoding RNA MALAT1 Promotes Malignant Development of Esophageal Squamous Cell Carcinoma by Targeting β-Catenin via Ezh2. Oncotarget, 7, 25668-25682. [Google Scholar] [CrossRef] [PubMed]
|
|
[61]
|
Wang, W., He, X., Zheng, Z., Ma, X., Hu, X., Wu, D. and Wang, M. (2017) Serum HOTAIR as a Novel Diagnostic Biomarker for Esophageal Squamous Cell Carcinoma. Molecular Cancer, 16, Article No. 75. [Google Scholar] [CrossRef] [PubMed]
|
|
[62]
|
Lin, K., Jiang, H., Zhuang, S.S., Qin, Y.S., Qiu, G.D., She, Y.Q., et al. (2018) Long Noncoding RNA LINC00261 Induces Chemosensitization to 5-Fluorouracil by Mediating Methyla-tion-Dependent Repression of DPYD in Human Esophageal Cancer. The FASEB Journal, 33, 1972-1988. [Google Scholar] [CrossRef]
|
|
[63]
|
Yoon, J.H., You, B.H., Park, C.H., Kim, Y.J., Nam, J.W. and Lee, S.K. (2018) The Long Noncoding RNA LUCAT1 Promotes Tumorigenesis by Controlling Ubiquitination and Stability of DNA Methyltransferase 1 in Esophageal Squamous Cell Carcinoma. Cancer Letters, 417, 47-57. [Google Scholar] [CrossRef] [PubMed]
|
|
[64]
|
Khalil, A.M., Guttman, M., Huarte, M., Garber, M., Raj, A., Rivea Morales, D., et al. (2009) Many Human Large Intergenic Noncoding RNAs Associate with Chromatin-Modifying Complexes and Affect Gene Expression. Proceedings of the National Academy of Sciences of the United States of America, 106, 11667-11672. [Google Scholar] [CrossRef] [PubMed]
|
|
[65]
|
He, L.R., Liu, M.Z., Li, B.K., Jia, W.H., Zhang, Y., Liao, Y.J., et al. (2010) High Expression of EZH2 Is Associated with Tumor Aggressiveness and Poor Prognosis in Patients with Esophageal Squamous Cell Carcinoma Treated with Definitive Chemoradiotherapy. International Journal of Cancer, 127, 138-147. [Google Scholar] [CrossRef] [PubMed]
|
|
[66]
|
Wang, H.R., Wang, M.H., Lian, G.Y. and Wu, D.G. (2015) Expression of Enhancer of Zeste Homolog 2 in Esophageal Squamous Cell Carcinoma and Its Prognostic Value in Postoperative Patients. Journal of Southern Medical University, 35, 99-102.
|
|
[67]
|
Ma, Z.B., Guo, G.H., Niu, Q. and Shi, N. (2014) Role of EZH2 Polymorphisms in Esophageal Squamous Cell Carcinoma Risk in Han Chinese Population. International Journal of Molecular Sciences, 15, 12688-12697. [Google Scholar] [CrossRef] [PubMed]
|
|
[68]
|
Li, W., Zheng, J., Deng, J., You, Y., Wu, H., Li, N., et al. (2014) In-creased Levels of the Long Intergenic Non-Protein Coding RNA POU3F3 Promote DNA Methylation in Esophageal Squamous Cell Carcinoma Cells. Gastroenterology, 146, 1714-1726.e5. [Google Scholar] [CrossRef] [PubMed]
|
|
[69]
|
Niu, G., Zhuang, H., Li, B. and Cao, G. (2018) Long Noncoding RNA Linc-UBC1 Promotes Tumor Invasion and Metastasis by Regulating EZH2 and Repressing E-Cadherin in Esophageal Squamous Cell Carcinoma. Journal of B.U.ON., 23, 157-162.
|
|
[70]
|
Lin, C., Huang, F., Li, Q.Z. and Zhang, Y.J. (2014) miR-101 Suppresses Tumor Proliferation and Migration, and Induces Apoptosis by Targeting EZH2 in Esophageal Cancer Cells. International Journal of Clinical and Experimental Pathology, 7, 6543-6550.
|
|
[71]
|
Xie, R., Wu, S.N., Gao, C.C., Yang, X.Z., Wang, H.G., Zhang, J.L., et al. (2017) MicroRNA-30d Inhibits the Migration and Invasion of Human Esophageal Squamous Cell Carcinoma Cells via the Posttranscriptional Regulation of Enhancer of Zeste Homolog 2. Oncology Reports, 37, 1682-1690. [Google Scholar] [CrossRef] [PubMed]
|
|
[72]
|
Huang, S.D., Yuan, Y., Zhuang, C.W., Li, B.L., Gong, D.J., Wang, S.G., et al. (2012) MicroRNA-98 and MicroRNA-214 Post-Transcriptionally Regulate Enhancer of Zeste Homolog 2 and Inhibit Migration and Invasion in Human Esophageal Squamous Cell Carcinoma. Molecular Cancer, 11, Article No. 51. [Google Scholar] [CrossRef] [PubMed]
|
|
[73]
|
Liang, Y., Chen, X., Wu, Y., Li, J., Zhang, S., Wang, K., et al. (2018) lncRNA CASC9 Promotes Esophageal Squamous Cell Carcinoma Metastasis through Upregulating LAMC2 Expression by Interacting with the CREB-Binding Protein. Cell Death & Differentiation, 25, 1980-1995. [Google Scholar] [CrossRef] [PubMed]
|
|
[74]
|
Li, Y., Li, J., Luo, M., Zhou, C., Shi, X., Yang, W., et al. (2018) Novel Long Noncoding RNA NMR Promotes Tumor Progression via NSUN2 and BPTF in Esophageal Squamous Cell Carcinoma. Cancer Letters, 430, 57-66. [Google Scholar] [CrossRef] [PubMed]
|
|
[75]
|
Dar, A.A., Nosrati, M., Bezrookove, V., de Semir, D., Majid, S., Thummala, S., et al. (2015) The Role of BPTF in Melanoma Progression and Inresponse to BRAF-Targeted Therapy. Journal of the National Cancer Institute, 107, djv034. [Google Scholar] [CrossRef] [PubMed]
|